These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
6. Subgroup analysis with semiparametric models toward precision medicine. Yuan A; Chen X; Zhou Y; Tan MT Stat Med; 2018 May; 37(11):1830-1845. PubMed ID: 29575056 [TBL] [Abstract][Full Text] [Related]
7. Subgroup identification for treatment selection in biomarker adaptive design. Lu TP; Chen JJ BMC Med Res Methodol; 2015 Dec; 15():105. PubMed ID: 26646831 [TBL] [Abstract][Full Text] [Related]
8. Controlling the false-discovery rate when identifying the subgroup benefiting from treatment. Schnell PM Clin Trials; 2023 Aug; 20(4):394-404. PubMed ID: 37122134 [TBL] [Abstract][Full Text] [Related]
9. A comparison of subgroup identification methods in clinical drug development: Simulation study and regulatory considerations. Huber C; Benda N; Friede T Pharm Stat; 2019 Oct; 18(5):600-626. PubMed ID: 31270933 [TBL] [Abstract][Full Text] [Related]
10. Subgroup analyses in randomised controlled trials: quantifying the risks of false-positives and false-negatives. Brookes ST; Whitley E; Peters TJ; Mulheran PA; Egger M; Davey Smith G Health Technol Assess; 2001; 5(33):1-56. PubMed ID: 11701102 [TBL] [Abstract][Full Text] [Related]
11. A Bayesian approach to subgroup identification. Berger JO; Wang X; Shen L J Biopharm Stat; 2014; 24(1):110-29. PubMed ID: 24392981 [TBL] [Abstract][Full Text] [Related]
12. Identification of subgroups via partial linear regression modeling approach. Zhou Y; Yuan A; Tan MT Biom J; 2022 Mar; 64(3):506-522. PubMed ID: 34897799 [TBL] [Abstract][Full Text] [Related]
13. A new and unified method for regression analysis of interval-censored failure time data under semiparametric transformation models with missing covariates. Lou Y; Ma Y; Du M Stat Med; 2024 May; 43(11):2062-2082. PubMed ID: 38757695 [TBL] [Abstract][Full Text] [Related]
14. Treatment evaluation for a data-driven subgroup in adaptive enrichment designs of clinical trials. Zhang Z; Chen R; Soon G; Zhang H Stat Med; 2018 Jan; 37(1):1-11. PubMed ID: 28948633 [TBL] [Abstract][Full Text] [Related]
15. Efficient targeted learning of heterogeneous treatment effects for multiple subgroups. Wei W; Petersen M; van der Laan MJ; Zheng Z; Wu C; Wang J Biometrics; 2023 Sep; 79(3):1934-1946. PubMed ID: 36416173 [TBL] [Abstract][Full Text] [Related]
16. Semiparametric bayesian testing procedure for noninferiority trials with binary endpoints. Osman M; Ghosh SK J Biopharm Stat; 2011 Sep; 21(5):920-37. PubMed ID: 21830923 [TBL] [Abstract][Full Text] [Related]
17. Change plane model averaging for subgroup identification. Liu P; Li J; Kosorok MR Stat Methods Med Res; 2023 Apr; 32(4):773-788. PubMed ID: 36775991 [TBL] [Abstract][Full Text] [Related]
18. Semi-parametric Bayesian regression for subgroup analysis in clinical trials. Gamalo-Siebers M; Tiwari R J Biopharm Stat; 2019; 29(6):1024-1042. PubMed ID: 30747568 [TBL] [Abstract][Full Text] [Related]
19. Targeted design for adaptive clinical trials via semiparametric model. Zhang H; Yuan A; Tan MT Int J Biostat; 2020 Oct; 17(2):177-190. PubMed ID: 33027048 [TBL] [Abstract][Full Text] [Related]
20. PSICA: Decision trees for probabilistic subgroup identification with categorical treatments. Sysoev O; Bartoszek K; Ekström EC; Ekholm Selling K Stat Med; 2019 Sep; 38(22):4436-4452. PubMed ID: 31246349 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]